The Problem: A CT Report That Says “Follow-Up Recommended”

You had a chest CT for something else — a cough, a routine physical, a pre-surgery screen — and now there is a line in the report you cannot stop reading. “Multiple pulmonary nodules. Recommend follow-up imaging.”

That sentence is terrifyingly vague, and it is also extremely common. Lung nodules turn up on roughly 1 in 4 chest CT scans performed in adults over 50, and the overwhelming majority are granulomas, scars, or benign lymph nodes. The American College of Radiology’s Lung-RADS framework exists precisely because radiologists needed a standardized way to say “this one matters” versus “this one probably does not.”

So why does it feel like nobody will tell you which category you are in? Because in most health systems, the answer depends on a follow-up scan three to six months away, and your appointment to discuss it is even further out. Meanwhile you are left searching at 2 a.m., reading about staging and five-year survival rates that may have nothing to do with your case.

The real question is not “do I have lung cancer.” It is narrower and more answerable: do these nodules have features that justify biopsy, surgery, or watchful waiting — and who is qualified to make that call?

Why a Shanghai Chest Team Changes the Picture

China treats an enormous volume of lung disease. That volume is not a marketing point — it is a structural fact that shapes how quickly and how confidently a thoracic team can classify nodules.

Reading Volume Builds Pattern Recognition

A thoracic radiologist at a major Shanghai center reviews chest imaging every working day, all day. Contrast that with a general radiologist in a smaller Western hospital who reads chest CT among abdominal, musculoskeletal, and neuro studies. Pattern recognition in nodule evaluation — margin characteristics, spiculation, pleural tagging, growth kinetics — improves with exposure. High-volume reading is not a guarantee of accuracy, but it is a genuine structural advantage.

MDT Is Standard, Not a Special Request

At China’s leading hospitals, complex nodule cases go to a multidisciplinary team: thoracic radiology, thoracic surgery, medical oncology, and pathology reviewing the same images together. In many Western systems, an MDT is something you hope your oncologist requests. In Shanghai’s top-tier centers, it is the default pathway for indeterminate or suspicious nodules. You get one consolidated recommendation instead of four opinions you have to reconcile yourself.

Cost and Access Without the Queue

Here is where the comparison gets concrete. A low-dose chest CT in a top Chinese public hospital typically runs $80–200. The same scan in the United States, without insurance negotiation, often bills at $500–1,500. A PET-CT, which is frequently the deciding study for a suspicious nodule, runs roughly $700–1,200 in China against $3,000–6,000 in the US.

Diagnostic turnaround is fast, too. Blood work, CT, and pathology results commonly return within 24–72 hours at major centers. That speed matters when you are waiting to learn whether a nodule needs surgery.

What a Shanghai Chest Evaluation Actually Involves

This is the part most guides skip. Here is the sequence, step by step.

Step 1: Records Review and Triage

You send your existing CT images — DICOM files on disc or a cloud link, not just the written report — plus any prior imaging. A prior scan is gold. Comparing a nodule today against one from 18 months ago answers more than any single study can.

A thoracic specialist reviews the images and sorts your case into one of three buckets: clearly benign (discharge with a surveillance plan), indeterminate (needs a defined follow-up interval or a PET-CT), or suspicious (needs tissue).

Step 2: Written Second Opinion or Video Consultation

This is where remote evaluation earns its place. You can obtain a written second opinion from a top-hospital specialist, typically in the $300–500 range, or a video consultation where you speak directly with the specialty team, from $500–800 for a top specialist. A multidisciplinary team video session, where several specialties review your case together, runs $1,500–2,000.

One mechanism worth knowing: any consultation fee is credited in full toward on-the-ground coordination if you travel to China within 90 days. It applies to the coordination fee only, never to hospital treatment charges, and it is a one-time credit.

Step 3: In-Person Evaluation in Shanghai

If the remote review says you need hands-on assessment, you come to Shanghai. Public hospital outpatient registration cannot be booked from overseas in advance — you take a number the day of your visit, and surgery can only be scheduled after an in-person consultation. That is the standard rule at public hospitals, and no service can bypass it.

What can be arranged in advance is the international or VIP channel, which gives you a senior specialist, English-speaking support, and a scheduled slot. Expect to pay roughly 1.5–2 times the standard consultation fee for that access.

Step 4: Diagnostic Procedures

Depending on the nodule, the team may recommend a repeat thin-slice CT, PET-CT, bronchoscopy with biopsy, or CT-guided percutaneous biopsy. Each has a specific role. A PET-CT helps characterize metabolic activity but is unreliable for nodules under 8–10 mm. A biopsy gives you tissue, which is the only way to definitively diagnose malignancy.

Reading Your Own Nodule Report: What the Numbers Mean

You do not need to become a radiologist. But understanding four variables will make every conversation sharper — with your local doctor or a Shanghai specialist.

Size alone is the crudest measure. A stable 9 mm smooth nodule that has not changed in three years is often less worrisome than a 7 mm part-solid nodule whose solid component doubled in eight months. Growth rate is frequently the single most informative variable, which is why retrieving your old scans matters so much.

Practical Considerations: Visas, Payment, and Records

For medical travel to China, the applicable short-stay visa category is S2, used for medical treatment and private affairs, subject to the latest embassy or consulate requirements and supporting hospital documents. Stays beyond 180 days fall under S1. Accompanying family members apply under S2 as well. Note that the M visa is for commercial and trade activity and has nothing to do with medical treatment — if a service tells you otherwise, that is a red flag.

Payment is straightforward but different from what many Western patients expect. Public hospitals require prepayment; insurance reimbursement happens afterward, in your home country. Private international hospitals often bill insurance directly. Bring your imaging on physical media as well as a cloud link — some hospital systems still prefer discs.

Records matter enormously. Request the DICOM files, not just the radiologist’s report. The images are the data. A written report tells the Shanghai team what someone else concluded; the images let them form their own view.

If you want to see which hospitals sit in China’s top tier before committing to anything, our ranked directory of top Chinese hospitals by city groups them by Fudan ranking tier, and the specialty rankings for oncology and thoracic surgery show which centers lead in lung cancer care specifically.

Frequently Asked Questions